IS7775A - DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru - Google Patents

DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru

Info

Publication number
IS7775A
IS7775A IS7775A IS7775A IS7775A IS 7775 A IS7775 A IS 7775A IS 7775 A IS7775 A IS 7775A IS 7775 A IS7775 A IS 7775A IS 7775 A IS7775 A IS 7775A
Authority
IS
Iceland
Prior art keywords
viral
transcribes
unmodified
dna vaccine
proteins
Prior art date
Application number
IS7775A
Other languages
English (en)
Inventor
Wayne Gough Gerald
Michael Roberts Christopher
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS7775A publication Critical patent/IS7775A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS7775A 2002-10-03 2005-03-29 DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru IS7775A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0222953.2A GB0222953D0 (en) 2002-10-03 2002-10-03 Novel Compounds
PCT/EP2003/011158 WO2004031222A2 (en) 2002-10-03 2003-10-01 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus

Publications (1)

Publication Number Publication Date
IS7775A true IS7775A (is) 2005-03-29

Family

ID=9945247

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7775A IS7775A (is) 2002-10-03 2005-03-29 DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru

Country Status (21)

Country Link
US (2) US20060165713A1 (is)
EP (1) EP1546191A2 (is)
JP (1) JP2006516386A (is)
KR (1) KR20050050115A (is)
CN (1) CN100393878C (is)
AR (1) AR041515A1 (is)
AU (1) AU2003294672A1 (is)
BR (1) BR0314986A (is)
CA (1) CA2500093A1 (is)
CO (1) CO5580837A2 (is)
GB (1) GB0222953D0 (is)
IS (1) IS7775A (is)
MA (1) MA27474A1 (is)
MX (1) MXPA05003558A (is)
NO (1) NO20051561L (is)
NZ (1) NZ539154A (is)
PL (1) PL376534A1 (is)
RU (1) RU2354701C2 (is)
TW (1) TW200411055A (is)
WO (1) WO2004031222A2 (is)
ZA (1) ZA200503201B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2241325T1 (sl) 2002-10-29 2012-05-31 Coley Pharm Group Inc Uporaba CPG oligonukleotidov pri zdravljenju okužbe z virusom hepatitisa C
AU2008209759B2 (en) * 2007-01-30 2013-03-21 Transgene S.A. Papillomavirus E2 polypeptide used for vaccination
GB0710538D0 (en) * 2007-06-01 2007-07-11 Glaxo Group Ltd Vaccine
EP2585107B1 (en) 2010-06-25 2018-10-24 Vaccibody AS Homodimeric protein constructs
MX2017005418A (es) * 2014-10-24 2017-11-30 Hpvvax Llc Tratamiento de cancer y lesion de piel.
US20190134190A1 (en) * 2016-05-04 2019-05-09 Transgene Sa Combination therapy with cpg tlr9 ligand

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN443995A0 (en) * 1995-07-27 1995-08-17 Csl Limited Papillomavirus polyprotein
DE60124918T2 (de) * 2000-07-21 2007-08-02 Glaxo Group Ltd., Greenford Kodon-optimierte papillomavirussequenzen
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences

Also Published As

Publication number Publication date
BR0314986A (pt) 2005-08-09
WO2004031222A3 (en) 2004-08-19
AR041515A1 (es) 2005-05-18
GB0222953D0 (en) 2002-11-13
NO20051561L (no) 2005-06-02
RU2354701C2 (ru) 2009-05-10
MA27474A1 (fr) 2005-08-01
EP1546191A2 (en) 2005-06-29
CO5580837A2 (es) 2005-11-30
KR20050050115A (ko) 2005-05-27
CN100393878C (zh) 2008-06-11
RU2005109155A (ru) 2006-03-10
PL376534A1 (pl) 2006-01-09
MXPA05003558A (es) 2005-06-03
NO20051561D0 (no) 2005-03-23
US20060165713A1 (en) 2006-07-27
TW200411055A (en) 2004-07-01
ZA200503201B (en) 2006-06-28
AU2003294672A1 (en) 2004-04-23
NZ539154A (en) 2007-05-31
WO2004031222A2 (en) 2004-04-15
US20070264283A1 (en) 2007-11-15
CA2500093A1 (en) 2004-04-15
JP2006516386A (ja) 2006-07-06
CN1720261A (zh) 2006-01-11

Similar Documents

Publication Publication Date Title
NO20044326D0 (no) Virale antigener
ITBS20030077A1 (it) Pinza pneumatica angolare.
EP1603590A4 (en) INFLUENZA VIRUS VACCINE
DK1716162T3 (da) Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
HK1123055A1 (en) Hepatitis c virus nucleic acid vaccine
NO20052149D0 (no) Vaksine.
ZA200704034B (en) Improved viral purification methods
NO331243B1 (no) Innleggsdel for gripeapparat.
HK1070670A1 (en) Improved viral purification methods
NO20040322L (no) Virus-polymerase-inhibitorer
BR0318327B1 (pt) garra cirérgica.
DE60329983D1 (de) Wachsestersynthase-dna-sequenz, protein und verwendungen davon
GB0206359D0 (en) Viral antigens
IS7775A (is) DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru
ITBS20030049A1 (it) Struttura di pinza pneumatica angolare.
IS8325A (is) Bóluefni
FI20055634A0 (fi) Ilmanerotusjärjestelmä
NL1026717A1 (nl) Verbindingen.
ATE437656T1 (de) Impfstoff gegen das maul- und klauensäure-virus
EP1593378A4 (en) MEDICINE FOR THE TREATMENT OF VIRUS DISEASES
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
EP1802332A4 (en) MODIFIED HIV-1 CREAM PROTEINS
GB0316199D0 (en) DNA viral infections
GB0216030D0 (en) DNA viral infections
ES1056663Y (es) Abrazadera.